Terry P. Gould - Director, 10%+ Owner at Corvus Pharmaceuticals, Inc.

Issuer-level insider activity

Role
Director, 10%+ Owner
Issuer ticker
CRVS on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Terry P. Gould since 13 Sep 2025

Reported holdings for Terry P. Gould in Corvus Pharmaceuticals, Inc.

Form 4 holding Director, 10%+ Owner

Corvus Pharmaceuticals, Inc.

Security class
Common Stock, $0.0001 par value
Shares / value
3,275,616
Estimated value
$5,670,746
Report date
13 Jun 2024
Price
$1.73
Ownership
By Funds
Form 4 holding Director, 10%+ Owner

Corvus Pharmaceuticals, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
15,000
Estimated value
Report date
13 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Terry P. Gould in Corvus Pharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .